Institut pasteur de Dakar
×

Error message

  • Unable to create CTools CSS cache directory. Check the permissions on your files directory.
  • Unable to create CTools CSS cache directory. Check the permissions on your files directory.

The Hepatitis B (HBV) Birth Vaccination in Africa (NEOVAC) project is a multidisciplinary (3 components: epidemiological, anthropological and economic) and multi-site (Senegal, Burkina Faso and Madagascar) study. While since 2009 WHO has recommended HBV vaccination within 24 hours of birth with a non-combined vaccine to prevent mother-to-child transmission, few African countries have implemented this vaccination. Even when the vaccine is made available to health facilities, it is rarely administered within 24 hours for various reasons. To date, no study has investigated strategies to improve immunization coverage at birth in sub-Saharan Africa. NEOVAC intends to develop a sustainable strategy adapted to the local context to vaccinate newborns against the hepatitis B virus within 24 hours and to improve neonatal care practices for babies born in a health establishment and those born in home.

Partners

Muraz
Lamivac
Institut Pasteur de Dakar
Institut Pasteur de Madagascar
Total Foundation